Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma

BACKGROUND: Postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) has improved overall survival (OS) in patients with hepatocellular carcinoma (HCC). However, the prognostic and predictive factors remain unclear. AIM: To assess the prognostic factors and the predictors of PA-TACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming-Yu, Juengpanich, Sarun, Hu, Jia-Hao, Topatana, Win, Cao, Jia-Sheng, Tong, Chen-Hao, Lin, Jian, Cai, Xiu-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081004/
https://www.ncbi.nlm.nih.gov/pubmed/32205995
http://dx.doi.org/10.3748/wjg.v26.i10.1042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081004/
https://www.ncbi.nlm.nih.gov/pubmed/32205995
http://dx.doi.org/10.3748/wjg.v26.i10.1042

Ejemplares similares